All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
People

Dermatology Residents Gather for Hands-on Cosmetic Training

admin
People

Chile Prepaid Card and Digital Wallet Intelligence Report 2025: Market to...

admin
People

Heartfelt Journey of Love and Growth Between Mother and Son

admin
Pr Newswire

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline

admin
Pr Newswire

MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual...

admin
Pr Newswire

Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodon’s Board...

admin
Pr Newswire

RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and...

admin
Pr Newswire

Norton Children’s announces new pediatric care campus, second dedicated pediatric hospital

admin
People

North America’s largest action sports festival, JACKALOPE Fest, returns to Mississauga’s...

admin
People

Guest Invest Announces Latest Discounts for Future Traders at The Best...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...